Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-004970
Filing Date
2025-11-14
Accepted
2025-11-14 14:30:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8444
  Complete submission text file 0000902664-25-004970.txt   10164
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Subject) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90861 | Film No.: 251484599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

EIN.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A